the present invention relates to the use of a specific compound , as described in detail below , having a high affinity to the peripheral benzodiazepine receptor for imaging cardiac and cardiovascular diseases for which inflammation and / or mitochondrial dysfunction and any other pathophysiological process leading to pbr activation are major contributing factor .